Azenta, Inc. cash flow statement
In fiscal 2025, Azenta, Inc.'s operations generated $72.2m of cash; it spent $33.9m on capital projects, leaving free cash flow of $38.3m.
Cash flow statement
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −56 | 28 | 88 | 36 | 54 | 54 | 44 | 40 | 96 | 74 | 91 | 38 | 150 | −466 | 6 | 50 | 72 | 38 |
| Depreciation and amortisation | 26 | 18 | 17 | 22 | 24 | 23 | 25 | 28 | 28 | 37 | 54 | 65 | 65 | 54 | 86 | 91 | 61 | 56 |
| Stock-based pay | 6 | 7 | 7 | 9 | 8 | 11 | 12 | 12 | 17 | 20 | 20 | 16 | 27 | 11 | 9 | 14 | 21 | 19 |
| Capital spending | 11 | 3 | 6 | 9 | 4 | 6 | 16 | 13 | 13 | 13 | 24 | 40 | 53 | 73 | 39 | 37 | 34 | 28 |
| Free cash flow | −68 | 24 | 81 | 27 | 51 | 48 | 28 | 27 | 84 | 61 | 67 | −2 | 97 | −539 | −34 | 12 | 38 | 10 |
| Free cash flow after stock pay | −74 | 18 | 74 | 19 | 43 | 37 | 15 | 15 | 66 | 41 | 47 | −18 | 70 | −550 | −43 | −2 | 17 | −9 |
| Dividends paid | — | — | 5 | 21 | 21 | 23 | 27 | 28 | 28 | 28 | 29 | 30 | 30 | 7 | 0 | 0 | — | — |
| Share buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 839 | 662 | 0 | — |
| Shares issued | — | — | — | — | — | — | 2 | 2 | 2 | 3 | 3 | 5 | 6 | 5 | 4 | 3 | 3 | — |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 18 | 30 | 14 | 26 | 2 | 21 | 14 | 1 |
| Depreciation and amortisation | 24 | 18 | 14 | 15 | 14 | 14 | 14 | 14 |
| Stock-based pay | 2 | 5 | 8 | 3 | 4 | 4 | 6 | 5 |
| Capital spending | 9 | 8 | 7 | 11 | 8 | 6 | 7 | 7 |
| Free cash flow | 8 | 22 | 7 | 15 | −6 | 15 | 6 | −5 |
| Free cash flow after stock pay | 6 | 17 | −1 | 12 | −10 | 11 | −0 | −10 |
| Shares issued | 2 | — | — | 0 | 1 | — | — | −0 |
Compare with peers
- 10x Genomics, Inc. cash flow
- Veracyte, Inc. cash flow
- Neogenomics Inc cash flow
- Repligen Corp cash flow
- Twist Bioscience Corp cash flow
Head to head: AZTA vs TXGAZTA vs VCYTAZTA vs NEOAZTA vs RGEN
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies